Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
äŒæ¥ã³ãŒãLH
äŒç€ŸåLabcorp Holdings Inc
äžå Žæ¥Apr 24, 1991
æé«çµå¶è²¬ä»»è
ãCEOãSchechter (Adam H)
åŸæ¥å¡æ°70000
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Apr 24
æ¬ç€Ÿæåšå°358 S Main St
éœåžBURLINGTON
蚌åžååŒæNASDAQ OMX NASDAQ Basic NYSE
åœUnited States of America
éµäŸ¿çªå·27215
é»è©±çªå·13362291127
ãŠã§ããµã€ãhttps://www.labcorp.com/
äŒæ¥ã³ãŒãLH
äžå Žæ¥Apr 24, 1991
æé«çµå¶è²¬ä»»è
ãCEOãSchechter (Adam H)